Inicio › Obesidad › Carolina del Norte › Wilmington
Ensayos clínicos de Obesidad en Wilmington, NC
15 estudios para Obesidad buscan participantes en centros de Wilmington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ReclutandoFase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ReclutandoFase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutandoFase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ReclutandoFase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ReclutandoFase 3
- Accellacare of Wilmington, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
ReclutandoFase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutandoFase 3
- Accellacare Research of Wilmington, Wilmington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutandoFase 3
- Accellacare Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutandoFase 3
- ACCOMPLISH-1 Research Site, Wilmington
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
ReclutandoFase 2
- Accellacare of Wilmington, Wilmington
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
ReclutandoFase 3
- Accellacare and KDCILM, LLC, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
ReclutandoFase 1
- Accellacare, Wilmington
Más información sobre Obesidad en MedlinePlus
Ensayos de Obesidad en otras ciudades
- Houston, TX43 estudios
- Chicago, IL41 estudios
- New York City, NY40 estudios
- San Antonio, TX40 estudios
- Washington, DC33 estudios
- Orlando, FL31 estudios
- Dallas, TX30 estudios
- Boston, MA28 estudios
- Las Vegas, NV27 estudios
- Miami, FL27 estudios
- Baltimore, MD25 estudios
- Jacksonville, FL25 estudios
Otros estudios en Wilmington
- Sobrepeso11 estudios
- Diabetes tipo 28 estudios
- Fallo cardíaco6 estudios
- Colitis ulcerativa4 estudios
- Presión arterial alta3 estudios
- Enfermedad cardiovascular3 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.